Ottawa, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The global multiple modalities in oncology market is advancing rapidly, with revenues expected to reach hundreds of millions between 2025 and 2034. This ...

Gemini Embedding 2 ships cross-modality retrieval with Matryoshka vectors, offering flexible dimensions for cost and accuracy tradeoffs.

Additional oral presentations explore odronextamab in areas of high unmet need, including the primary analysis in diffuse large B-cell lymphoma progressing after CAR-T therapy and first results in ...